• Current Issue:
    3articles Vol.1(2024)
    Sort by
    Most Downloaded
    Open Access
    Original Article
    Four hepatic steatosis indices in predicting quantitative computed tomography-based metabolic dysfunction-associated fatty liver disease
    Aim: To evaluate the prediction ability for quantitative computed tomography (QCT)-based metabolic dysfunction-associated fatty liver disease (MAFLD) of four widely known hepatic steatosis algori [...] Read more.
    Bingwu Xu ... Yong Zhang
    Published: May 23, 2024 Explor Endocr Metab Dis. 2024;1:62–76
    DOI: https://doi.org/10.37349/eemd.2024.00008
    This article belongs to the special issue Regulators of Glucose Homeostasis, Lipid Metabolism and Energy Balance
    View:15
    Download:6
    Times Cited: 0
    Open Access
    Original Article
    Epigenetics in etiopathology of hyperprolactinemia
    Aim: Epigenetic alterations have been reported in patients with pituitary tumors and those on antipsychotic drugs, which are also responsible for hyperprolactinemia. This suggests a possible role [...] Read more.
    Amanpreet Kaur Kalsi ... Jai Bhagwan Sharma
    Published: May 22, 2024 Explor Endocr Metab Dis. 2024;1:39–55
    DOI: https://doi.org/10.37349/eemd.2024.00006
    This article belongs to the special issue The HPA Axis in Health and Disease
    View:37
    Download:5
    Times Cited: 0
    Open Access
    Perspective
    Diabetes and cancer: two epidemic diseases requiring an opposite therapeutic approach to target cells
    Diabetes and cancer are two chronic metabolic diseases with ever-increasing incidence rates worldwide. These disorders can often occur together, as diabetes presents an important risk factor for can [...] Read more.
    Katrin Sak
    Published: May 23, 2024 Explor Endocr Metab Dis. 2024;1:56–61
    DOI: https://doi.org/10.37349/eemd.2024.00007
    View:27
    Download:4
    Times Cited: 0